@article{CCO1462,
author = {Robert Rees},
title = {A new rat model of prostate cancer},
journal = {Chinese Clinical Oncology},
volume = {2},
number = {3},
year = {2013},
keywords = {},
abstract = {The current status of immunotherapy of cancer dictates that tumour cells should express appropriate antigenic peptides on the cell surface associated with MHC class I antigen. Therapies designed to activate immunity against cell surface expressed target peptides are required to induce antigen specific cytotoxic T-lymphocytes (CTL) capable of mediating tumour rejection and that such immune responses should produce immunological memory. The necessity for both MHC class I (CTL response) and class II (T-helper response) - restricted responses has been well documented and the nature of tumour antigens expressed on a wide variety of human cancers widely reported.},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/1462}
}